FDA Inspection 1066468 — Eurofarma, Inc.
The FDA completed an inspection of Eurofarma, Inc. on Aug 14, 2018 in Parsippany, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Parsippany, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)